News on molecular diagnostics, pharmacogenomics tests for coronary artery disease, congenital heart defects, and more.
The iQ Group Global is integrating the Wyss Institute's technology with its own organic thin-film biosensor platform for SARS-CoV-2 serology testing.
The firm has grown its SomaScan platform to measure 7,000 proteins and will have developed around 20 clinical tests on the platform by the end of the year.
Weill Cornell Medicine, New York-Presbyterian Hospital, and the New York Genome Center will join Illumina to sequence the genomes of thousands of patients.
The partnership will provide new point-of-care lipid testing devices to remote sites in Latin America, the Caribbean, and Asia-Pacific.
The FDA does not allow labs to report hs-troponin results below assays' limits of quantitation, which some argue leaves actionable information on the table.
